M&A is a major growth strategy, and tech and life sciences companies are leading the charge with billions in transactions. What does this mean for risk managers and how can agents and brokers support their customers? In this webinar, part two of our three-part series on mergers and acquisitions, we explore Travelers’ 2025 M&A study findings on tech and life sciences. Learn more about the data trends, regional differences and sentiments of executives and risk professionals who have gone through a merger or acquisition.
This program is the second webinar in a three-part series on Travelers’ 2025 M&A study. Explore the series:
Part one: Mastering M&A: Strategies for Risk Management Part three: Mastering M&A: Risk Management in Manufacturing Transitions